<DOC>
	<DOC>NCT00139646</DOC>
	<brief_summary>This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.</brief_summary>
	<brief_title>Parecoxib in Renal Colic</brief_title>
	<detailed_description>This study was prematurely discontinued May 3, 2004 due to slow recruitment. The decision to terminate the trial was not based on any safety concerns.</detailed_description>
	<mesh_term>Colic</mesh_term>
	<mesh_term>Renal Colic</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>diagnosis of renal colic; baseline pain &gt; 50 mm on VAS; evidence of neoplasm or any other severe disease of any organ, including any psychiatric illness; active GI disease (e.g. Crohn's disease or ulcerative colitis) or any evidence of concomitant disease which may lead to early termination of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>